Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: China's Exports and Crimea's Crisis Leave Investors Uneasy
View this photo on glassdoor.com
Bristol-Myers: Don't Let This One Get Away
AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is
GSK's lung cancer drug Tafinlar gets FDA breakthrough therapy status
GlaxoSmithKline Plc: Forgotten FTSE Favourite Will Shine Again
GlaxoSmithKline added to SG Premium List at Societe Generale
Young Investors: Go Global, Get International Stocks!
NPL links up with GlaxoSmithKline to support research into new medicines
GSK Taflinar pockets Breakthrough Therapy designation
Former GlaxoSmithKline exec joins Neuralstem board - Washington Business Journal
Risk Seen With Merck & Co., Inc.-GlaxoSmithKline Rotavirus Vaccines